Osaka, Japan

Kenya Kawashima

This inventor holds 1 USPTO granted patent. Top assignee: Takeda Chemical Industries, Inc.. Active years: 1976.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 1976

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kenya Kawashima: Innovator in Pharmaceutical Chemistry

Introduction

Kenya Kawashima is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patent work. His research focuses on the synthesis of valuable intermediates for drug development.

Latest Patents

Kenya Kawashima holds a patent for a compound titled "1 - 1,1-Dichloro-1a, 10b-dihydrodibenzo(b,f)cycloprop(d)azepine-6(1H)-carboxaldehyde." This compound is produced in good yield through a reaction involving a specific compound formula, where R can represent either a hydrogen or formyl group, along with chloroform. The resulting product serves as a valuable intermediate for synthesizing medicines and can be converted into known drugs, such as 6-(3-dimethylamino)propyl)-1, 1a, 6, 10b-tetrahydrodibenzo(b,f)cycloprop(d)azepine. He has 1 patent to his name.

Career Highlights

Kenya Kawashima is associated with Takeda Chemical Industries, Inc., a leading pharmaceutical company. His work at Takeda has allowed him to contribute to the development of innovative pharmaceutical solutions. His expertise in chemical synthesis has positioned him as a valuable asset in the industry.

Collaborations

Kenya has collaborated with notable colleagues, including Yasuhiko Kawano and Toshihiro Ishiguro. These collaborations have fostered a productive environment for research and innovation within the pharmaceutical sector.

Conclusion

Kenya Kawashima's contributions to pharmaceutical chemistry through his patent work exemplify the importance of innovation in drug development. His ongoing efforts continue to impact the field positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…